ERBB2 and breast carcinoma: We also show here that whereas PMCA4 abundance is associated with longer relapse-free patient survival in luminal LUMA (grade 2) and LUMB1 breast cancer subtypes, the opposite is observed for patients with HER2 positive LUMB2 breast cancer (Fig. 1d).